Protoporphyrin biosynthesis in Melanoma B16 cells stimulated by 5‐aminolevulinic acid and chemical inducers: Characterization of photodynamic inactivation
暂无分享,去创建一个
Z. Malik | Y. Nordenberg | N. Schoenfeld | R. Mamet | Z Malik | R Mamet | N Schoenfeld | Y Nordenberg | M Shafran | T Babushkin | M. Shafran | T. Babushkin
[1] H. Dailey,et al. Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase. , 1984, The Biochemical journal.
[2] R. Morimoto,et al. Sequential activation of genes for heme pathway enzymes during erythroid differentiation of mouse Friend virus-transformed erythroleukemia cells. , 1991, Biochimica et biophysica acta.
[3] L. Kwock,et al. Stereotactic intratumoral photodynamic therapy for recurrent malignant brain tumors. , 1991, Neurosurgery.
[4] I. Favilla,et al. Phototherapy of posterior uveal melanomas. , 1991, The British journal of ophthalmology.
[5] P. Charlesworth,et al. The use of 5-aminolevulinic acid (ALA) in photodynamic therapy (PDT). , 1993, Journal of photochemistry and photobiology. B, Biology.
[6] Z. Malik,et al. Chemical inducers of differentiation, dimethylsulfoxide, butyric acid, and dimethylthiourea, induce selective ultrastructural patterns in B16 melanoma cells , 1987, Biology of the cell.
[7] R. Kinne,et al. Structural state of the Na+/D-glucose cotransporter in calf kidney brush-border membranes. Target size analysis of Na+-dependent phlorizin binding and Na+-dependent D-glucose transport. , 1984, Biochimica et biophysica acta.
[8] P. Sinclair,et al. Heme regulates hepatic 5-aminolevulinate synthase mRNA expression by decreasing mRNA half-life and not by altering its rate of transcription. , 1991, Archives of biochemistry and biophysics.
[9] Z. Malik,et al. Cell-death induced by discrete processes: Its reflection in cellular ion content revealed by X-ray microanalysis , 1992 .
[10] N. Navone,et al. Heme biosynthesis in human breast cancer--mimetic "in vitro" studies and some heme enzymic activity levels. , 1990, The International journal of biochemistry.
[11] H. Breitbart,et al. THE EFFECTS OF PHOTOACTIVATED PROTOPORPHYRIN ON RETICULOCYTE MEMBRANES, INTRACELLULAR ACTIVITIES and HEMOGLOBIN PRECIPITATION , 1982, Photochemistry and photobiology.
[12] N. Schoenfeld,et al. Experimental latent and acute porphyria in the non-fasted rat; preventive effect of propranolol. , 1991, Scandinavian journal of clinical and laboratory investigation.
[13] Z. Malik,et al. Inactivation of erythrocytic, lymphocytic and myelocytic leukemic cells by photoexcitation of endogenous porphyrins. , 1989, Journal of photochemistry and photobiology. B, Biology.
[14] Z. Malik,et al. Destruction of erythroleukemia, myelocytic leukemia and burkitt lymphoma cells by photoactivated protoporphyrin , 1980, International journal of cancer.
[15] M. W. Roomi,et al. Drug-induced porphyrin biosynthesis. 8. Investigation of the importance of an allyl group for activity in substituted acetamides. , 1973, Canadian journal of physiology and pharmacology.
[16] N. Schoenfeld,et al. High-performance liquid chromatographic detection of pitfalls in porphobilinogen deaminase determination. , 1991, Journal of chromatography.
[17] D. Buell,et al. Erythroid differentiation in cultured Friend leukemia cells treated with metabolic inhibitors. , 1976, Cancer research.
[18] Z. Malik,et al. Biochemical and ultrastructural alterations accompany the anti-proliferative effect of butyrate on melanoma cells. , 1987, British Journal of Cancer.
[19] Z. Malik,et al. Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. , 1987, British Journal of Cancer.
[20] J Moan,et al. Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5‐aminolevulinic acid in mice bearing mammary carcinoma , 1992, International journal of cancer.
[21] S. Sassa,et al. The effects of acute-phase inducers and dimethyl sulphoxide on delta-aminolaevulinate synthase activity in human HepG2 hepatoma cells. , 1989, The Biochemical journal.
[22] K König,et al. In vivo photoproduct formation during PDT with ALA-induced endogenous porphyrins. , 1993, Journal of photochemistry and photobiology. B, Biology.
[23] N. Schoenfeld,et al. The heme biosynthetic pathway in lymphocytes of patients with malignant lymphoproliferative disorders. , 1988, Cancer letters.
[24] J Hanania,et al. The effect of EDTA and serum on endogenous porphyrin accumulation and photodynamic sensitization of human K562 leukemic cells. , 1992, Cancer letters.
[25] C. Puliafito,et al. Photodynamic therapy for experimental intraocular melanoma using chloroaluminum sulfonated phthalocyanine. , 1989, Archives of ophthalmology.
[26] Z. Malik,et al. Collapse of K+ and ionic balance during photodynamic inactivation of leukemic cells, erythrocytes and Staphylococcus aureus. , 1993, The International journal of biochemistry.
[27] J C Kennedy,et al. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. , 1992, Journal of photochemistry and photobiology. B, Biology.
[28] Z. Malik,et al. Stimulation of Friend erythroleukemic cell cytodifferentiation by 5-amino levulinic acid; porphyrins, cell size, segregation of sialoglycoproteins, and nuclear translocation. , 1988, Experimental hematology.
[29] R. van Hillegersberg,et al. Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats. , 1992, Gastroenterology.
[30] C. Lim,et al. Urine and faecal porphyrin profiles by reversed-phase high-performance liquid chromatography in the porphyrias. , 1984, Clinica chimica acta; international journal of clinical chemistry.
[31] T. Dubbelman,et al. Photodynamic effects of hematoporphyrin-derivative on transmembrane transport systems of murine L929 fibroblasts. , 1984, Biochimica et biophysica acta.
[32] M. Berns,et al. Photodynamic therapy of human malignant melanoma xenografts in athymic nude mice. , 1988, Journal of the National Cancer Institute.
[33] P. Berk,et al. A model for calculating enzyme synthetic rates during induction: application to the synergistic effect of ferric citrate on the induction of hepatic delta-aminolevulinic acid synthetase. , 1969, Life sciences.
[34] N. Schoenfeld,et al. Increased porphobilinogen deaminase activity in patients with malignant lymphoproliferative diseases. A helpful diagnostic test. , 1987, JAMA.
[35] S. Wrighton,et al. Differential apoprotein loss of rat liver cytochromes P450 after their inactivation by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine: a case for distinct proteolytic mechanisms? , 1992, Archives of biochemistry and biophysics.
[36] D. Phillips,et al. Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model. , 1992, British Journal of Cancer.